EN
0
Home > Products > Pharmaceuticals & Life Science > Pharmaceutical Intermediates > (3R,5S,6R,7R,10S,13R)-6-ethyl-17-((R)-5-hydroxypentan-2-yl)-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol
(3R,5S,6R,7R,10S,13R)-6-ethyl-17-((R)-5-hydroxypentan-2-yl)-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol structure, CAS 1537866-49-1

(3R,5S,6R,7R,10S,13R)-6-ethyl-17-((R)-5-hydroxypentan-2-yl)-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol

CAS Number1537866-49-1

Synonyms

Molecular FormulaC26H46O3

Molecular Weight406.65

Purity

Density

Boiling Point

Melting Point

Flash Point

Appearance

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-3179673 Purity:
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Inquiry

Quality Control of [ 1537866-49-1 ] SDS Specification MoL

COA NMR CNMR HPLC LC-MS
Chemical & Physical Properties
CAS Number1537866-49-1
Catalog No.2A-3179673
Chinese Name奥贝胆酸杂质 18
Molecular FormulaC26H46O3
Molecular Weight406.65
PubChem ID274716801
MDL NumberMFCD30738007
InChIInChI=1S/C26H46O3/c1-5-18-22-15-17(28)10-12-26(22,4)21-11-13-25(3)19(16(2)7-6-14-27)8-9-20(25)23(21)24(18)29/h16-24,27-29H,5-15H2,1-4H3/t16-,17-,18-,19-,20+,21+,22+,23+,24-,25-,26-/m1/s1
InChI KeyDQBAHTQWQZRMFH-JDCMAIOWSA-N
Transport InfoProduct name: Obeticholic acid impurity 7
Related Products in Pharmaceutical Intermediates
((1R,2R)-2-(((3aR,4S,7R,7aS)-1,3-dioxooctahydro-2H-4,7- methanoisoindol-2-yl)methyl)cyclohexyl)methyl 4-(benzo[d] isothiazol-3-yl)piperazine-1-carboxylate1807983-62-52A-3179630
((1R,2R)-cyclohexane-1,2-diyl)bis(methylene) bis(4-(benzo[d] isothiazol-3-yl)piperazine-1-carboxylate)1807983-61-42A-3179631
(3aR,4R,7S,7aS)-rel-2-[[(1R,2R)-2-[[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione hydrochloride (1:1)139563-24-92A-3179633
(R)-4-((3R,5S,6S,7S,10S,13R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid1708092-13-02A-3179669
(R)-4-((3R,5S,6S,7R,10S,13R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid915038-27-62A-3179672
(4R)-4-((3R,5R,10R,13R)-6-ethylidene-3-hydroxy-10,13-dimethyl-7-oxohexadeca hydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid915038-24-32A-3179676
(4R)-4-[(3S,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid566-24-52A-3179679
(5Z)-N-(Cyclopropylmethyl)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxy-4-phenoxy-1-buten-1-yl]cyclopentyl]-5-heptenamide1138395-09-12A-2179690
5-Bromo-3-nitro-1H-pyrrolo[2,3-b]pyridine507462-26-22A-3179720
4-(2'-N-BOC-HYDRAZINO)BENZOIC ACID96736-00-42A-3179733
Browse all Pharmaceutical Intermediates products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA